UB Paderborn / Katalog / Suche / in CDI

Using Seroprevalence and Immunisation Coverage Data to Estimate the Global Burden of Congenital Rubella Syndrome, 1996-2010: A Systematic Review

PloS one, 2016-03, Vol.11 (3), p.e0149160-e0149160

2016

Link zum Volltext

Verfügbarkeit prüfen

Mapping vaccination coverage to explore the effects of delivery mechanisms and inform vaccination strategies

Nature communications, 2019-04, Vol.10 (1), p.1633-10, Article 1633

2019

Link zum Volltext

Verfügbarkeit prüfen

Multilevel analysis of predictors of multiple indicators of childhood vaccination in Nigeria

PloS one, 2022-05, Vol.17 (5), p.e0269066-e0269066

2022

Link zum Volltext

Verfügbarkeit prüfen

Benefits and Challenges in Using Seroprevalence Data to Inform Models for Measles and Rubella Elimination

The Journal of infectious diseases, 2018-07, Vol.218 (3), p.355-364

2018

Link zum Volltext

Verfügbarkeit prüfen

Correction: Implementing WHO guidance on conducting and analysing vaccination coverage cluster surveys: Two examples from Nigeria

PloS one, 2021-06, Vol.16 (6), p.e0253670-e0253670

2021

Link zum Volltext

Verfügbarkeit prüfen

Implementing WHO guidance on conducting and analysing vaccination coverage cluster surveys: Two examples from Nigeria

PloS one, 2021-02, Vol.16 (2), p.e0247415-e0247415

2021

Link zum Volltext

Verfügbarkeit prüfen

Pneumococcal antibody concentrations and carriage of pneumococci more than 3 years after infant immunization with a pneumococcal conjugate vaccine

PloS one, 2012-02, Vol.7 (2), p.e31050-e31050

2012

Link zum Volltext

Verfügbarkeit prüfen

Evaluating the impact of the HIV pandemic on measles control and elimination

Bulletin of the World Health Organization, 2005-05, Vol.83 (5), p.329-337

2005

Link zum Volltext

Verfügbarkeit prüfen

Comparison of measles IgG enzyme immunoassays for measuring measles serostatus: a systematic review of head-to-head analyses of measles IgG EIA and PRNT

BMC infectious diseases, 2023-05, Vol.23 (1)

2023

Link zum Volltext

Verfügbarkeit prüfen

Chapter 15: HPV vaccine use in the developing world

Vaccine, 2006-08, Vol.24, p.S132-S139

2006

Link zum Volltext

Verfügbarkeit prüfen

Measuring Coverage in MNCH: Design, Implementation, and Interpretation Challenges Associated with Tracking Vaccination Coverage Using Household Surveys: e1001404

PLoS medicine, 2013-05, Vol.10 (5)

2013

Link zum Volltext

Verfügbarkeit prüfen

Measuring Coverage in MNCH: Total Survey Error and the Interpretation of Intervention Coverage Estimates from Household Surveys: e1001386

PLoS medicine, 2013-05, Vol.10 (5)

2013

Link zum Volltext

Verfügbarkeit prüfen

WITHDRAWN: Geospatial variation in measles vaccine coverage through routine and campaign strategies in Nigeria: analysis of recent household surveys

Vaccine: X, 2020-02, p.100056, Article 100056

2020

Link zum Volltext

Verfügbarkeit prüfen

Erratum: Estimation of intervention effects using first or multiple episodes in clinical trials: The Andersen-Gill model re-examined

Statistics in medicine, 2010-12, Vol.29 (29), p.3068-3068

2010

Link zum Volltext

Verfügbarkeit prüfen

Monitoring progress toward US preschool immunization goals

JAMA : the journal of the American Medical Association, 1992-04, Vol.267 (14), p.1952

1992

Link zum Volltext

Verfügbarkeit prüfen

Persistence of Vaccine-Induced Measles Antibody Beyond Age 12 Months: A Comparison of Response to One and Two Doses of Edmonston- Zagreb Measles Vaccine Among HIV-Infected and Uninfected Children in Malawi: Global Progress Toward Measles Eradication and Prevention of Rubella and Congenital Rubella Syndrome

The Journal of infectious diseases, 2011, Vol.204

2011

Link zum Volltext

Verfügbarkeit prüfen

Reply to Arya and Agarwal

The Journal of infectious diseases, 2006-01, Vol.193 (1), p.166-167

2006

Link zum Volltext

Verfügbarkeit prüfen

Multilevel analysis of predictors of multiple indicators of childhood vaccination in Nigeria

PloS one, 2022-01, Vol.17 (5), p.e0269066

2022

Link zum Volltext

Verfügbarkeit prüfen

Risk of death from pneumococcal pneumonia is a stable serotype-associated property: a meta-analysis

Clinical infectious diseases, 2010-09, Vol.51 (6), p.692-699

2010

Link zum Volltext

Verfügbarkeit prüfen

Rural Kenya: Measles during Pregnancy and Early Infancy/Reply to Arya and Agarwal

The Journal of infectious diseases, 2006-01, Vol.193 (1), p.165

2006

Link zum Volltext

Verfügbarkeit prüfen

Comparison of a commercial enzyme immunoassay with plaque reduction neutralization for maternal and infant measles antibody measurement

Revista do Instituto de Medicina Tropical de São Paulo, 1999-01, Vol.41 (1), p.21-26

1999

Link zum Volltext

Verfügbarkeit prüfen

Using Seroprevalence and Immunisation Coverage Data to Estimate the Global Burden of Congenital Rubella Syndrome, 1996-2010: A Systematic Review: e0149160

PloS one, 2016-03, Vol.11 (3)

2016

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of polysaccharide pneumococcal vaccine in adults in more developed countries: another view of the evidence

The Lancet infectious diseases, 2003-05, Vol.3 (5), p.273-274

2003

Link zum Volltext

Verfügbarkeit prüfen

Immunization in developing countries

Vaccines, 2013, p.1369-1394

Sixth Edition, 2013

Link zum Volltext

Verfügbarkeit prüfen

Ensuring access to HPV vaccines through integrated services: a reproductive health perspective/Garantir l'acces aux vaccins HPV grace a un systeme de services integres: point de vue de la sante genesique/Garantizar el acceso a las vacunas contra el PVH mediante servicios integrados: una perspectiva de salud reproductiva

Bulletin of the World Health Organization, 2007-01, Vol.85 (1), p.57

2007

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Using Seroprevalence and Immunisation Coverage Data to Estimate the Global Burden of Congenital Rubella Syndrome, 1996-2010: A Systematic Review

Mapping vaccination coverage to explore the effects of delivery mechanisms and inform vaccination strategies

Multilevel analysis of predictors of multiple indicators of childhood vaccination in Nigeria

Benefits and Challenges in Using Seroprevalence Data to Inform Models for Measles and Rubella Elimination

Correction: Implementing WHO guidance on conducting and analysing vaccination coverage cluster surveys: Two examples from Nigeria

Implementing WHO guidance on conducting and analysing vaccination coverage cluster surveys: Two examples from Nigeria

Pneumococcal antibody concentrations and carriage of pneumococci more than 3 years after infant immunization with a pneumococcal conjugate vaccine

Evaluating the impact of the HIV pandemic on measles control and elimination

Comparison of measles IgG enzyme immunoassays for measuring measles serostatus: a systematic review of head-to-head analyses of measles IgG EIA and PRNT

Chapter 15: HPV vaccine use in the developing world

Measuring Coverage in MNCH: Design, Implementation, and Interpretation Challenges Associated with Tracking Vaccination Coverage Using Household Surveys: e1001404

Measuring Coverage in MNCH: Total Survey Error and the Interpretation of Intervention Coverage Estimates from Household Surveys: e1001386

WITHDRAWN: Geospatial variation in measles vaccine coverage through routine and campaign strategies in Nigeria: analysis of recent household surveys

Erratum: Estimation of intervention effects using first or multiple episodes in clinical trials: The Andersen-Gill model re-examined

Monitoring progress toward US preschool immunization goals

Reply to Arya and Agarwal

Multilevel analysis of predictors of multiple indicators of childhood vaccination in Nigeria

Risk of death from pneumococcal pneumonia is a stable serotype-associated property: a meta-analysis

Rural Kenya: Measles during Pregnancy and Early Infancy/Reply to Arya and Agarwal

Comparison of a commercial enzyme immunoassay with plaque reduction neutralization for maternal and infant measles antibody measurement

Using Seroprevalence and Immunisation Coverage Data to Estimate the Global Burden of Congenital Rubella Syndrome, 1996-2010: A Systematic Review: e0149160

Efficacy of polysaccharide pneumococcal vaccine in adults in more developed countries: another view of the evidence

Immunization in developing countries

Aktive Filter

Suchergebnisse filtern